FilingReader Intelligence

Everest Medicines to re-elect directors, seek share mandates

June 3, 2025 at 05:04 PM UTC•By FilingReader AI

Everest Medicines (HKEX:1952) has announced its upcoming Annual General Meeting (AGM) on June 27, 2025, where shareholders will vote on key resolutions including the re-election of executive directors Wei Fu, Yongqing Luo, and Ian Ying Woo, who are offering themselves for re-election. Also to be approved is the proposed re-appointment of Ernst & Young as the auditor.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

(1) PROPOSED RE-ELECTION OF DIRECTORS; (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; (3) PROPOSED RE-APPOINTMENT OF RETIRING AUDITOR; (4) NON-EXEMPTED CONNECTED TRANSACTIONS - PROPOSED GRANT OF AWARDS AND PERFORMANCE TARGET AWARDS TO CONNECTED PERSONS; AND (5) NOTICE OF ANNUAL GENERAL MEETINGJune 3, 2025 at 08:37 AM UTC

Supplementary Source Documents

NOTICE OF ANNUAL GENERAL MEETINGJune 3, 2025 at 08:38 AM UTC

The Pre-IPO Employee Equity PlanJune 3, 2025 at 08:42 AM UTC

Everest Medicines

HKEX:1952•Hong Kong Exchange

RSS feed for Everest Medicines

News Alerts

Get instant email alerts when Everest Medicines publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →